Conclusions: Blood transfusion in anaemic preterm infants was associated with improvements in cerebral regional oxygenation, left ventricular cardiac output and reduced variability in non-cerebral regional oxygenation. Methods: An international, multi-centre, cross-sectional study with a pre-defined study period of 10-15 days per participating unit between December 2015 and March 2017. Infants ≤28 days of age who received a fluid bolus (≥10ml/kg given over ≤6 hours) for haemodynamic compromise were included across the 41 participating units.
AN INTERNATIONAL, MULTI-CENTRE, CROSS-SECTIONAL STUDY OF FLUID BOLUS THERAPY IN NEONATES
Methods: An international, multi-centre, cross-sectional study with a pre-defined study period of 10-15 days per participating unit between December 2015 and March 2017. Infants ≤28 days of age who received a fluid bolus (≥10ml/kg given over ≤6 hours) for haemodynamic compromise were included across the 41 participating units.
Results: A total of 163 neonates received a bolus over 8479 eligible patient days. Prevalence of fluid bolus therapy varied between centres from 0% to 28.6% of admitted neonates per day, with a pooled prevalence rate of 1.5% (95% confidence interval 1.1-1.9%). The most common fluid used was 0.9% sodium chloride (129/163; 79%) but a range of fluids types were administered. The volume of fluid administered was most commonly 10mL/kg (115/163; 71%) over a median of 30 (interquartile range 20-60) minutes. More frequent indications were hypotension (n=56; 34%), poor perfusion (n=20; 12%) and metabolic acidosis (n=20; 12%). Little or no clinical improvement was reported by clinicians in 66/163 (40%) neonates. Mortality during study period of observation was 7%.
Conclusions: Wide variations in types, indications and effects of fluid bolus administration in haemodynamically compromised neonates suggest uncertainty in the risk-benefit profile. There is a need for clinically powered randomised studies. Aims: To perform a pilot randomised controlled trial to determine feasibility and provide preliminary data for a large randomised controlled trial of 670 nm red light treatment for the prevention of ROP.
Methods: Neonates < 30 weeks gestation or < 1150 grams at birth were randomised to receive 670 nm to the whole body for 15 minutes (9J/cm
